BrainStorm Cell Therapeutics Inc (BCLI)

[Fmello]

As we get closer and closer to the end of November, what's your gut feeling about how things will play out. My guess:

The stock will slowly fight it's way up to the $15-$20 range by the end of the month. If we get FDA approval, I can see the stock price quickly double or triple. On the slim chance that Brainstorm does not get FDA approval, then my guess is that the stock price will plummet 60-75%.